{"id":10856,"date":"2015-02-10T00:00:00","date_gmt":"2015-02-09T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2015\/02\/10\/nace-combacte-magnet-un-proyecto-europeo-para-fomentar-el-desarrollo-de-antibioticos-en-europa\/"},"modified":"2020-05-21T08:53:55","modified_gmt":"2020-05-21T06:53:55","slug":"nace-combacte-magnet-un-proyecto-europeo-para-fomentar-el-desarrollo-de-antibioticos-en-europa","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2015\/02\/nace-combacte-magnet-un-proyecto-europeo-para-fomentar-el-desarrollo-de-antibioticos-en-europa\/","title":{"rendered":"Nace COMBACTE-MAGNET, un proyecto europeo para fomentar el desarrollo de antibi\u00f3ticos en Europa"},"content":{"rendered":"

34 centros de investigaci\u00f3n y cinco compa\u00f1\u00edas farmac\u00e9uticas han puesto en marcha el proyecto COMBACTE-MAGNET enmarcado en el programa de investigaci\u00f3n New Drugs 4 Bad Bugs (ND4BB) de la iniciativa europea sobre Medicamentos Innovadores (IMI). El objetivo del proyecto es fomentar el desarrollo de antibi\u00f3ticos en Europa a trav\u00e9s de estudios y actividades relacionados con la prevenci\u00f3n y el tratamiento de infecciones causadas por bacterias Gram-negativas resistentes a m\u00faltiples f\u00e1rmacos (MDR-GNB).
La UMC de Utrecht en los Pa\u00edses Bajos es la coordinadora del proyecto que cuenta con la colaboraci\u00f3n de Miquel Pujol del grupo de investigaci\u00f3n en epidemiolog\u00eda de las infecciones bacterianas del IDIBELL y el Hospital Universitario de Bellvitge.
El proyecto COMBACTE-MAGNET investigar\u00e1 un nuevo enfoque para la prevenci\u00f3n de las infecciones respiratorias en pacientes de la UCI y nuevas opciones de tratamiento para los pacientes con infecciones potencialmente mortales debido a MDR-GNB.
COMBACTE-MAGNET colaborar\u00e1 estrechamente para fortalecer a\u00fan m\u00e1s las redes cl\u00ednicas y de laboratorio de COMBACTE, el primer proyecto dentro del programa ND4BB que comenz\u00f3 en enero de 2013. Adem\u00e1s, se crear\u00e1 una colaboraci\u00f3n paneuropea (llamada EPI-Net) en COMBACTE- MAGNET para mapear y utilizar los sistemas de vigilancia disponibles en Europa con el fin de describir de manera \u00f3ptima la epidemiolog\u00eda de la resistencia a los antibi\u00f3ticos y las infecciones con la asistencia sanitaria.<\/p>\n","protected":false},"excerpt":{"rendered":"

34 centros de investigaci\u00f3n y cinco compa\u00f1\u00edas farmac\u00e9uticas han puesto en marcha el proyecto COMBACTE-MAGNET enmarcado en el programa de investigaci\u00f3n New Drugs 4 Bad Bugs (ND4BB) de la iniciativa europea sobre Medicamentos Innovadores (IMI). El objetivo del proyecto es fomentar el desarrollo de antibi\u00f3ticos en Europa a trav\u00e9s de estudios y actividades relacionados con […]<\/p>\n","protected":false},"author":6,"featured_media":10857,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[186,339,295],"tags":[275],"publishpress_future_action":{"enabled":false,"date":"2024-05-12 01:29:35","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10856"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=10856"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10856\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/10857"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=10856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=10856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=10856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}